- Home
- OPRA vs JANX Comparison
OPRA vs JANX Comparison
Compare OPRA & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRA
- JANX
- Stock Information
- Founded
- OPRA 1996
- JANX 2017
- Country
- OPRA Norway
- JANX United States
- Employees
- OPRA N/A
- JANX N/A
- Industry
- OPRA Computer Software: Prepackaged Software
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- OPRA Technology
- JANX Health Care
- Exchange
- OPRA Nasdaq
- JANX Nasdaq
- Market Cap
- OPRA 1.3B
- JANX 1.6B
- IPO Year
- OPRA 2018
- JANX 2021
- Fundamental
- Price
- OPRA $16.98
- JANX $25.56
- Analyst Decision
- OPRA Strong Buy
- JANX Strong Buy
- Analyst Count
- OPRA 5
- JANX 7
- Target Price
- OPRA $24.90
- JANX $94.29
- AVG Volume (30 Days)
- OPRA 578.6K
- JANX 929.3K
- Earning Date
- OPRA 04-28-2025
- JANX 05-08-2025
- Dividend Yield
- OPRA 4.66%
- JANX N/A
- EPS Growth
- OPRA N/A
- JANX N/A
- EPS
- OPRA 0.93
- JANX N/A
- Revenue
- OPRA $521,494,000.00
- JANX $9,336,000.00
- Revenue This Year
- OPRA $20.00
- JANX N/A
- Revenue Next Year
- OPRA $15.66
- JANX $250.58
- P/E Ratio
- OPRA $18.46
- JANX N/A
- Revenue Growth
- OPRA 26.68
- JANX 28.12
- 52 Week Low
- OPRA $10.11
- JANX $22.52
- 52 Week High
- OPRA $22.50
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- OPRA 56.07
- JANX 37.10
- Support Level
- OPRA $17.01
- JANX $24.13
- Resistance Level
- OPRA $17.62
- JANX $33.97
- Average True Range (ATR)
- OPRA 0.63
- JANX 2.01
- MACD
- OPRA 0.23
- JANX -0.61
- Stochastic Oscillator
- OPRA 81.89
- JANX 14.53
About OPRA Opera Limited
Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.